Plant Extracts in Hyperoxaluria Treatment: A Review of Experimental and Clinical Research
This article is a review of the scientific literature. The purpose of this research was the systematization of the updated information on potential herbal medicine in hyperoxaluria treatment. We analysed the English language scientific literature Medline published from January 2008 to December 2018. Data in vitro, experimental and clinical studies demonstrated antiurolithiatic properties of many plant extracts. Reducing hyperoxaluria is mainly caused by the ability of plants to inhibit nucleation and agglomeration of crystals by changing the ionic composition of urine and due to diuretic, nephroprotective, antioxidant and antibacterial effects.
Türk C, Petřík A, Sarica K, Seitz C, Skolarikos A, Straub M, Knoll T. EAU Guidelines on Diagnosis and Conservative Management of Urolithiasis. Eur Urol 2016;69:468–74. [CrossRef]
2. Robijn S, Hoppe B, Vervaet BA, D'Haese PC, Verhulst A. Hyperoxaluria: a gut-kidney axis? Kidney Int 2011;80:1146–58. [CrossRef]
3. Knight J, Holmes RP, Assimos DG. Intestinal and renal handling of oxalate loads in normal individuals and stone formers. Urol Res 2007;35:111–117. [CrossRef]
4. Marengo SR, Romani AM. Oxalate in renal stone disease: the terminal metabolite that just won't go away. Nat Clin Pract Nephrol 2008;4:368–77. [CrossRef]
5. Glew RH, Sun Y, Horowitz BL, Konstantinov KN, Barry M, Fair JR, et al. Nephropathy in dietary hyperoxaluria: A potentially preventable acute or chronic kidney disease. World J Nephrol 2014;3:122–42. [CrossRef]
6. Harambat J, Fargue S, Bacchetta J, Acquaviva C, Cochat P. Primary hyperoxaluria. Int J Nephrol 2011;2011:864580. [CrossRef]
7. Bhasin B, Ürekli HM, Atta MG. Primary and secondary hyperoxaluria: Understanding the enigma. World J Nephrol 2015;4:235–244. [CrossRef]
8. Barnela SR, Soni SS, Saboo SS, Bhansali AS. Medical management of renal stone. Indian J Endocrinol Metab 2012;16:236– 239. [CrossRef]
9. Morgan Monica S C, Pearle Margaret S. Medical management of renal stones BMJ 2016;352:i52. [CrossRef]
10. Azarfar A, Esmaeili M, Tousi N, Naseri M, Ghane F, Ravanshad Y, Alizadeh A. Evaluation of the effects of magnesium supplement in primary and secondary preventions of nephrolithiasis: a systematic review. Reviews in Clinical Medicine 2016;3:18–22.
11. Butterweck V, Khan SR. Herbal medicines in the management of urolithiasis: alternative or complementary? Planta Med 2009;75:1095–1103. [CrossRef]
12. Nirumand MC, Hajialyani M, Rahimi R, Farzaei MH, Zingue S, Nabavi SM, Bishayee A. Dietary Plants for the Prevention and Management of Kidney Stones: Preclinical and Clinical Evidence and Molecular Mechanisms. Int J Mol Sci 2018;19:765.
13. Stepanova N. Lactobacillus probiotic decreases urinary oxalate excretion in non-stone formers women with recurrent pyelonephritis. Eur Urol Suppl 2016;17:e1367. [CrossRef]
14. Hatch M, Gjymishka A, Salido EC, Allison MJ, Freel RW. Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization with Oxalobacter. Am J Physiol Gastrointest Liver Physiol 2011;300:G461–G469. [CrossRef]
15. Milliner D, Hoppe B, Groothoff J. A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria. Urolithiasis 2018;46:313–323. [CrossRef]
16. Yadav RD, Alok SS, Jain SK, Verma A, Mahor A, Verma A, Mahor A, Bharti JP, Jaiswal M. Herbal plants used in the treatment of urolithiasis: a review. IJPSR 2011;2:1412–1420.
17. Havagiray RC, Shashi A, Jain SK, Sabharwal M. Herbal treatment for urinary stones. IJPSR 2010;3:24–31.
18. Bahmani M, Baharvand-Ahmadi B, Tajeddini P, RafieianKopaei M, Naghdi N. Identification of medicinal plants for the treatment of kidney and urinary stones. J Renal Inj Prev 2016;5:129–133. [CrossRef]
19. Prachi N, Chauhan D, Kumar M S. Medicinal plants of muzaffarnagar distict used in treatment of urinary tract and kidney stone. Indian journal of traditional knowledge 2009;8:191– 195.
20. Akram M, Idrees M. Progress and prospects in the management of kidney stones and developments in phytotherapeutic modalities. Int J Immunopathol Pharmacol 2019;33:2058738419848220. [CrossRef]
21. Tiwari A, Soni V, Londhe V, Bhandarkar A, Bandawane DD, Nipate SS. An overview on potent indigenous herbs for urinary tract infirmity: urolithiasis. Asian J Pharm Clin Res 2012;5:7–12.
22. Pareta SK, Patra KC, Mazumder PM, r Sasmal D. Establishing the Principle of Herbal Therapy for Antiurolithiatic Activity: A Review. J Toxicol Pharmacol 2011;6:321–332. [CrossRef]
23. Sundaramoorthi P, Kalainathan S. Crystal Growth of Some Renal Stones Constituents: In vitro Crystallization of Trace Element and Its Characterization Studies. Journal of Minerals & Materials Characterization & Engineering 2007;6:17–24. [CrossRef]
24. Pareta SK, Patra KC, Mazumder PM, Sasmal D. Boerhaavia Diffusa Linn aqueous extract as curative agent in ethylene glycol induced urolithiasis. Pharmacologyonline 2010;3:112–120.
25. Goyal KP, Arun M, Rishi K. Evaluation of tinospora cordifolia for antiurolithiatic potential. Journal of Pharmaceutical and Biomedical Sciences 2011;9:1–15.
26. Barzgarnejad A, Azadbakht M, Emadian O. In vitro effect of ju-niper fruit extract on dissolution of urinary stones. J Mazand Univ Med Sci 2010;20:31–36.
27. Khan A, Bashir S, Khan SR, Gilani AH. Antiurolithic activity of Origanum vulgare is mediated through multiple pathways. BMC Complement Altern Med 2011;11:96. [CrossRef]
28. Tayal S, Duggal S, Bandyopadhyay P, Aggarwal A, Tandon S, Tandon C. Cytoprotective role of the aqueous extract of Terminalia chebula on renal epithelial cells. Int Braz J Urol 2012;38:204–13; discussion 213–4. [CrossRef]
29. Khan A, Khan SR, Gilani AH. Studies on the in vitro and in vivo antiurolithic activity of Holarrhena antidysenterica. Urol Res 2012;40:671–681. [CrossRef]
30. Bouanani S, Henchiri C, Migianu-Griffoni E, Aouf N, Lecouvey M. Pharmacological and toxicological effects of Paronychia argentea in experimental calcium oxalate nephrolithiasis in rats. J Ethnopharmacol 2010;129:38–45. [CrossRef]
31. Kachkoul R, Sqalli Houssaini T, Miyah Y, Mohim M, El Habbani R, Lahrichi A. The study of the inhibitory effect of calcium oxalate monohydrate's crystallization by two medicinal and aromatic plants: Ammi visnaga and Punica granatum. Prog Urol 2018;28:156–165. [CrossRef]
32. Pareta SK, Patra K, Harwansh RK. In-vitro calcium oxalate crystallization inhibition by achyranthes indica linn. Hydroalcoholic extract: an approach to antilithiasis. Int J Pharma Bio Sci 2011;2:432–7.
33. Ahmadi M, Rad AK, Rajaei Z, Hadjzadeh MA, Mohammadian N, Tabasi NS. Alcea rosea root extract as a preventive and curative agent in ethylene glycol-induced urolithiasis in rats. Indian J Pharmacol 2012;44:304–307. [CrossRef]
34. Bhagavathula AS, Mahmoud Al-Khatib AJ, Elnour AA, Al Kalbani NM, Shehab A. Ammi Visnaga in treatment of urolithiasis and hypertriglyceridemia. Pharmacognosy Res 2015;7:397– 400. [CrossRef]
35. Aggarwal A, Singla SK, Gandhi M, Tandon C. Preventive and curative effects of Achyranthes aspera Linn. extract in experimentally induced nephrolithiasis. Indian J Exp Biol 2012;50:201–8.
36. Wang S, Li X, Bao J, Chen S. Protective potential of Angelica sinensis polysaccharide extract against ethylene glycol-induced calcium oxalate urolithiasis. Ren Fail 2018;40:618–627.
37. Kachkoul R, Sqalli Houssaini T, Habbani R, Miyah Y, Mohim M, Lahrichi A. Phytochemical screening and inhibitory activity of oxalocalcic crystallization of Arbutus unedo L. leaves. Heliyon. 2018;4:e01011. [CrossRef]
38. Bashir S, Gilani AH. Antiurolithic effect of berberine is mediated through multiple pathways. Eur J Pharmacol 2011;651:168– 75. [CrossRef]
39. Yasir F, Waqar MA. Effect of indigenous plant extracts on calcium oxalate crystallization having a role in urolithiasis. Urol Res 2011;39:345–350. [CrossRef]
40. Rodgers A, Mokoena M, Durbach I, Lazarus J, de Jager S, Ack-ermann H, et al. Do teas rich in antioxidants reduce the physicochemical and peroxidative risk factors for calcium oxalate nephrolithiasis in humans? Pilot studies with Rooibos herbal tea and Japanese green tea. Urolithiasis 2016;44:299–310.
41. De Cógáin MR, Linnes MP, Lee HJ, Krambeck AE, de Mendonça Uchôa JC, Kim S-H, Lieske JC. Aqueous extract of Costus arabicus inhibits calcium oxalate crystal growth and adhesion to renal epithelial cells. Urolithiasis 2015;43:119–24. [CrossRef]
42. Patankar S, Dobhada S, Bhansali M, Khaladkar S, Modi J. A prospective, randomized, controlled study to evaluate the efficacy and tolerability of Ayurvedic formulation "varuna and banana stem" in the management of urinary stones. J Altern Complement Med 2008;14:1287–90. [CrossRef]
43. Agarwal S, Gupta SJ, Saxena AK, Gupta N, Agarwal S. Urolithic property of Varuna (Crataeva nurvala): An experimental study. Ayu 2010;31:361–366. [CrossRef]
44. Ibrahima FY, El-Khateeb AY. Effect of herbal beverages ofFoeniculum vulgareand Cymbopogon proximuson inhibition of calcium oxalaterenal crystals formation in rats. Annals of Agricultural Sciences 2013;58:221–229. [CrossRef]
45. Singh RG, Behura SK, Kumar R. Litholytic property of Kulattha (Dolichous biflorus) vs potassium citrate in renal calculus disease: a comparative study. J Assoc Physicians India 2010;58:286–9.
46. Saha S, Verma RJ. Evaluation of hydro-alcoholic extract of Dolichos biflorus seeds on inhibition of calcium oxalate crystallization. J Herb Med 2015;5:41–47. [CrossRef]
47. Orhan N, Onaran M, Şen İ, Gönül İI, Aslan M. Preventive treatment of calcium oxalate crystal deposition with immortal flowers. J Ethnopharmacol 2015;2:60–7. [CrossRef]
48. Woottisin S, Hossain RZ, Yachantha C, Sriboonlue P, Ogawa Y, Saito S. Effects of Orthosiphon grandiflorus, Hibiscus sabdariffa and Phyllanthus amarus extracts on risk factors for urinary calcium oxalate stones in rats. J Urol 2011;185:323–8. [CrossRef]
49. Kumkum A., Ranjana V. Inhibition of calcium oxalate crystallization in - vitro by various extracts of Hyptis Suaveolens (l.) Poit. IRGP 2012;3:261–7.
50. Barzgarnejad A, Azadbakht M, Emadian O, Fattahi M. In vitroeffect of juniper fruit extract on dissolutionof urinary stones. J Mazandaran Univ Med Sci 2010;20:31–6.
51. Makasana A, Ranpariya V, Desai D, Mendpara J, Parekh V. Evaluation for the anti-urolithiatic activity of Launaea procumbens against ethylene glycol-induced renal calculi in rats. Toxicol Rep 2014;1:46–52. [CrossRef]
52. Fahad JV , Kumar MS, Kodancha G , Adarsh B, Udupa A, Rathnakar U. Antiurolithiatic activity of aqueous extract of bark of moringa oleifera (lam.) in rats. Health 2010;2:352–355. [CrossRef]
53. Premgamone A, Sriboonlue P, Maskasem S, Ditsataporncharoen W, Jindawong B. Orthosiphon versus placebo in nephrolithiasis with multiple chronic complaints: a randomized control trial. Evid Based Complement Alternat Med 2009;6:495–501. [CrossRef]
54. Tracy CR, Henning JR, Newton MR, Aviram M, Zimmerman MB. Oxidative stress and nephrolithiasis: A comparative pilot study evaluating the effect of pomegranate extract on stone risk factors and elevated oxidative stress levels of recurrent stone formers and controls. Urolithiasis 2014;42:401–8. [CrossRef]
55. Li X, Wang W, Su Y, Yue Z, Bao J. Inhibitory effect of an aqueous extract of Radix Paeoniae Alba on calcium oxalate nephrolithiasis in a rat model. Ren Fail 2017;39:120–129. [CrossRef]
56. Divakar K, Pawar AT, Chandrasekhar SB, Dighe SB, Divakar G. Protective effect of the hydro-alcoholic extract of Rubia cordifolia roots against ethylene glycol induced urolithiasis in rats. Food Chem Toxicol 2010;48:1013–8. [CrossRef]
57. Tayefi-Nasrabadi H, Sadigh-Eteghad S, Aghdam Z. The effects of the hydroalcohol extract of Rosa canina L. fruit on experimentally nephrolithiasic Wistar rats. Phytother Res 2012;26:78–85. [CrossRef]
58. Haug KG, Weber B, Hochhaus G, Butterweck V. Nonlinear pharmacokinetics of visnagin in rats after intravenous bolus administration. Eur J Pharm Sci 2012;45:79–89. [CrossRef]
59. Fink HA, Akornor JW, Garimella PS, et al. Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of randomized trials. Eur Urol 2009;56:72–80. [CrossRef]